Book contents
- 55 Cases in Neurology
- 55 Cases in Neurology
- Copyright page
- Contents
- Preface
- Acknowledgements
- Section 1 Visual Disturbance
- Section 2 Headache and Pain
- Section 3 Weakness
- Section 4 Behavioural and Language Changes
- Section 5 Confusion
- Section 6 Movement Disturbances
- Section 7 Acute Onset of Neurological Symptoms
- Index
- Plate Section (PDF Only)
- References
Section 1 - Visual Disturbance
Published online by Cambridge University Press: 27 July 2023
Book contents
- 55 Cases in Neurology
- 55 Cases in Neurology
- Copyright page
- Contents
- Preface
- Acknowledgements
- Section 1 Visual Disturbance
- Section 2 Headache and Pain
- Section 3 Weakness
- Section 4 Behavioural and Language Changes
- Section 5 Confusion
- Section 6 Movement Disturbances
- Section 7 Acute Onset of Neurological Symptoms
- Index
- Plate Section (PDF Only)
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- 55 Cases in NeurologyCase Histories and Patient Perspectives, pp. 1 - 66Publisher: Cambridge University PressPrint publication year: 2023
References
References
Ordunez-Garcia, PO, Nieto, FJ, Espinosa-Brito, AD, Caballero, B. Cuban epidemic neuropathy, 1991 to 1994: history repeats itself a century after the ‘amblyopia of the blockade’. Am J Public Health. 1996 May;86(5):738–43.CrossRefGoogle ScholarPubMed
Denny-Brown, D. Neurological conditions resulting from prolonged and severe dietary restriction; case reports in prisoners-of-war, and general review. Medicine (Baltimore). 1947 Feb.;26(1):41–113.CrossRefGoogle ScholarPubMed
Thomas, PK, Plant, GT, Baxter, P, Bates, C, Santiago Luis, R. An epidemic of optic neuropathy and painful sensory neuropathy in Cuba: clinical aspects. J Neurol. 1995 Oct.;242(10):629–38.CrossRefGoogle ScholarPubMed
References
Biousse, V, Newman, NJ. Diagnosis and clinical features of common optic neuropathies. Lancet Neurol. 2016;15(13):1355–67.CrossRefGoogle ScholarPubMed
Kirkman, MA, Yu-Wai-Man, P, Korsten, A et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132(9):2317–26.CrossRefGoogle ScholarPubMed
Catarino, CB, von Livonius, B, Priglinger, C et al. Real-world clinical experience with idebenone in the treatment of Leber hereditary optic neuropathy. J Neuro-Ophthalmology. 2020;40(4):558–65.CrossRefGoogle ScholarPubMed
Biousse, V, Newman, NJ, Yu-Wai-Man, P et al. Long-term follow-up after unilateral intravitreal gene therapy for Leber hereditary optic neuropathy: the RESTORE study. J Neuro-Ophthalmology. 2021;41(3):309–15.CrossRefGoogle ScholarPubMed
References
Rennebohm, RM, Asdaghi, N, Srivastava, S, Gertner, E. Guidelines for treatment of Susac syndrome: An update. Int J Stroke Off J Int Stroke Soc. 2020;15(5):484–94.Google ScholarPubMed
Gross, CC, Meyer, C, Bhatia, U et al. CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nat Commun. 2019;10(1):5779.CrossRefGoogle ScholarPubMed
Kleffner, I, Dörr, J, Ringelstein, M et al. Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry. 2016;87(12):1287–95.CrossRefGoogle ScholarPubMed
References
Lublin, FD, Reingold, SC, Cohen, JA et al. Defining the clinical course of multiple sclerosis. Neurology 2014;83(3):278–86.CrossRefGoogle ScholarPubMed
Lucchinetti, C, Bruck, W, Parisi, J, Scheithauer, B, Rodriguez, M, Lassmann, H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47(6):707–17.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
Thompson, AJ, Banwell, BL, Barkhof, F et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.Google ScholarPubMed
Institute of Medicine. Improving Diagnosis in Health Care. Washington, DC: National Academies of Sciences, Engineering, and Medicine, 2015 (http://iom.nationalacadmies.org/Reports/2015/Improving-Diagnosis-in-Healthcare.aspx), page 2.Google Scholar
References
Koukkoulli, A, Koutroumanos, N, Kidd, D. Perineural spread of cutaneous squamous cell carcinoma manifesting as ophthalmoplegia. Neuro-Ophthalmology. 2015;39(3):144–6.CrossRefGoogle ScholarPubMed
Mendenhall, WM, Amdur, RJ, Hinerman, RW et al. Skin cancer of the head and neck with perineural invasion. Am J Clin Oncol Cancer Clin Trials. 2007;30(1):93–6.Google ScholarPubMed
Vickrey, BG, Samuels, MA, Ropper, AH. How neurologists think a cognitive psychology perspective on missed diagnoses. Ann Neurol. 2010;67(4):425–33.CrossRefGoogle ScholarPubMed
References
Friedman, DI, Liu, GT, Digre, KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–65.CrossRefGoogle ScholarPubMed
McCluskey, G, Doherty-Allan, R, McCarron, P et al. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol. 2018;25(10):1218–27.CrossRefGoogle ScholarPubMed
Mollan, SP, Davies, B, Silver, NC et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89:1088–100.CrossRefGoogle ScholarPubMed
References
Jarius, S, Wildemann, B. The history of neuromyelitis optica. J Neuroinflammation. 2013;10(8):1–12.CrossRefGoogle ScholarPubMed
Lennon, VA, Wingerchuk, DM, Kryzer, TJ et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106–12.CrossRefGoogle ScholarPubMed
Wingerchuk, DM, Banwell, B, Bennett, JL et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.CrossRefGoogle ScholarPubMed
References
Juryńczyk, M, Jacob, A, Fujihara, K, Palace, J. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations. Pract Neurol. 2019;19(3):187–95.CrossRefGoogle ScholarPubMed
Jurynczyk, M, Messina, S, Woodhall, MR et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128–38.CrossRefGoogle ScholarPubMed
Denève, M, Biotti, D, Patsoura, S et al. MRI features of demyelinating disease associated with anti-MOG antibodies in adults. J Neuroradiol. 2019;46(5):312–8.CrossRefGoogle ScholarPubMed
References
Ropper, AH, Klein, J. Cerebral venous thrombosis. N Engl J Med. 2021;385:59–64.CrossRefGoogle ScholarPubMed
Bentley, P, Sharma, P. Distinguishing early from late seizures after cerebral venous thrombosis: cinderepilepsy. Neurology. 2020;95(12):513–14.CrossRefGoogle ScholarPubMed
Ferro, JM, Bousser, MG, Canhão, P et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis: endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203–13.CrossRefGoogle ScholarPubMed